Prothena collects $60M Parkinson's milestone from Roche; AstraZeneca's Pascal Soriot faces proxy pushback on pay package
Working on a Parkinson’s treatment in a collaboration with Roche, Prothena has collected its latest milestone in pursuit of that end goal.
The biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.